A Study of GZR18 Injection in Chinese Patients With Type 2 Diabetes Mellitus

Inclusion Criteria

• •(1) Chinese adults, male or female aged between 18 and 75 (including both ends).
• •(2) According to the diagnostic and classification criteria of diabetes issued by the World Health Organization (WHO) in 1999, and the supplementary diagnostic criteria of WHO in 2011, type 2 diabetes was diagnosed for more than 3 months.
• •(3) Lifestyle intervention and / or unregulated use of antidiabetic drugs within 3 months before screening, or stable use of less than 3 oral hypoglycemic drugs within 3 months before screening.
• •(4) HbA1c (HbA1c) ≥ 7.0% and ≤ 11% during screening.
• •(5) Body mass index (BMI) ≥ 18.5 kg/m2.
• •(6) There is no birth plan within 6 months from the signing of informed consent to the last administration, and those who voluntarily take effective contraceptive measures and have no sperm donation plan. Fertile women are not breastfeeding, and the screening and baseline pregnancy tests must be negative.
• •(7) Patients fully understand the purpose, nature, methods and possible adverse reactions of the trial, can communicate well with researchers, and can understand and comply with the requirements of this study. During the study, they can maintain a stable diet and exercise lifestyle, and voluntarily sign an informed consent form to enter this study.